Please login to the form below
Actilyse
This page shows the latest Actilyse news and features for those working in and with pharma, biotech and healthcare.
Daiichi Sankyo licenses clot-busting antibody
as Genentech/Boehringer Ingelheim's Activase/Actilyse (alteplase), but Translational Sciences believes there is significant room for improvement.
Latest news
More from news
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
-
Senior Medical Writer
-
Great salary and benefits
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
-
Digital Account Director
-
Salary TBC
-
Account Director, Medical Education
-
Salary TBC
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
-
Project Manager/ Account Manager
-
Salary TBC
-
Senior Medical Writer
-
Up to £50, 000 with Benefits
-
Senior Medical Writer
-
Salary TBC
Subscribe to our email news alerts
- Drug launches to watch in 2019
- Welcome to the Communique Awards - Communiqué Awards 2018
- ‘Inflexible’ NICE blocking access to rare disease drugs
- GW Pharma's cannabis-based medicine to be tested in dementia
- Immuno-oncology in 2019: the rapid evolution continues
- 2019: CRISPR and therapeutic gene editing comes of age
- The importance of co-creation with patients
- McCann Health's next challenge: creative differentiation
- Greater Manchester backs move to outcome-based payment
- Merck & Co to buy IO specialists Immune Design for $300m
- More good news, and some bad, for Merck’s Keytruda
- Xencor’s Novartis-partnered bispecific on hold after patient deaths
PMHub
Cello Health
Cello Health’s mission is to help our clients unlock the potential that exists with their assets, brands and organisations in...
Latest intelligence
- The importance of co-creation with patients
- Overcoming the barriers...
- Three billboards on the road to multichannel
- Chris Ross examines the trends driving multichannel communication in 2019...
- How Medisafe is using AI to improve patient adherence
- Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....
Quick links
Infographics
